1-4 of 4
David McConkey
Close
Sort by
Journal Articles

Proteasome and HDAC: who's zooming who?

David McConkey
Journal: Blood
Blood (2010) 116 (3): 308–309.
https://doi.org/10.1182/blood-2010-04-278507
Published: 2010
Journal Articles

Inhibition of the Pan-Bcl-2 Family by the Small Molecule GX15-070 Induces Apoptosis in Mantle Cell Lymphoma (MCL) Cells and Enhances the Activity of Two Proteasome Inhibitors (NPI-0052 and Bortezomib), and Doxorubicin Chemotherapy.

Victor Y. Yazbeck, MD, Georgios V. Georgakis, M.D., Yang Li, David McConkey, Michael Andreeff, Anas Younes
Journal: Blood
Blood (2006) 108 (11): 2532.
https://doi.org/10.1182/blood.V108.11.2532.2532
Published: 2006
Journal Articles

The Novel, Orally Active Proteasome Inhibitor, NPI-0052, Induces Apoptosis in Leukemia Lymphoma Cell Lines and Patient Specimens.

Claudia P. Miller, MS, Kechen Ban, PhD, Stacey L. Ruiz, Saskia Neuteboom, PhD, Michael Palladino, PhD, David McConkey, PhD, Joya Chandra, PhD
Journal: Blood
Blood (2005) 106 (11): 241.
https://doi.org/10.1182/blood.V106.11.241.241
Published: 2005
Journal Articles

Phase 2 Study of Three Doses of Single Agent Bortezomib in Patients with Fludarabine-Refractory B-Cell CLL.

Stefan Faderl, MD, Kanti R. Rai, MD, John Gribben, MD, Ian Flinn, MD, John C. Byrd, MD, David McConkey, PhD, David Schenkein, MD, Dixie Esseltine, MD, Mary L. Browning, RN, Michael J. Keating, MD
Journal: Blood
Blood (2004) 104 (11): 4841.
https://doi.org/10.1182/blood.V104.11.4841.4841
Published: 2004